A. Jiblaoui et al. / Tetrahedron 69 (2013) 5098e5103
5103
over MgSO4. The residue was purified by preparative silica gel
References and notes
(petroleum ether/CHCl3: 60/40), to give 6 as a green solid (27 mg,
26%). The remainder of the material was a mixture of 6 and 7.
1. Miyatake, T.; Tamiaki, H. Coord. Chem. Rev. 2010, 254, 2593e2602.
2. Flores-Rojas, G. G.; Lijanova, I. V.; Morales-Saavedra, O. G.; Sanchez-Montes, K.;
Martínez-García, M. Dyes Pigm. 2013, 96, 125e129.
4.1.5.2. New procedure. Porphyrin 2 (1 equiv,17 mg, 0.02 mmol),
4 (1.2 equiv, 20 mg, 0.024 mmol), PdCl2(PPh3)2 (0.14 equiv, 2 mg,
0.0028 mmol), Ph3As (0.6 equiv, 3.5 mg, 0.011 mmol) and TBAF
(100 equiv, 2 mL, 1 M in THF 5% water) was combined in a ground
flask. The mixture was stirred at reflux for 4 h until disappearance
of compound 5 on TLC. The reaction was quenched by adding DCM;
the solution was washed with water (75 mL) and dried over MgSO4.
The residue was purified by preparative silica gel (petroleum ether/
CHCl3: 60/40), to give 6 (17 mg, 57%).
3. Drouet, S.; Merhi, A.; Argouarch, G.; Paul, F.; Mongin, O.; Blanchard-Desce, M.;
Paul-Roth, C. O. Tetrahedron 2012, 68, 98e105.
4. (a) Garcia, G.; Hammerer, F.; Poyer, F.; Achelle, S.; Teulade-Fichou, M.-P.;
Maillard, P. Bioorg. Med. Chem. 2013, 21, 153e165; (b) Makhseed, S.; Al-Sawah,
M.; Samuel, J.; Manaa, H. Tetrahedron Lett. 2009, 50, 165e168.
5. (a) Bonnett, R. Chemical Aspects of Photodynamic Therapy; Gordon and Breach
Science: 2000; (b) Chaleix, V.; Sol, V.; Huang, Y.-M.; Guilloton, M.; Granet, R.;
Blais, J. C.; Krausz, P. Eur. J. Org. Chem. 2003, 1486e1493; (c) Sol, V.; Chaleix, V.;
Granet, R.; Krausz, P. Tetrahedron 2008, 64, 364e371.
6. (a) Schmidt-Erfurth, U.; Hasan, T. Surv. Ophthalmol. 2000, 45, 195e214;
(b) He, X.-Y.; Sikes, R. A.; Thomsen, S.; Chung, L. W. K.; Jacques, S. L.
Photochem. Photobiol. 1994, 59, 468e473.
7. (a) Bhawalkar, J. D.; Kumar, N. D.; Zhao, C. F.; Prasad, P. N. J. Clin. Lasers
Med. Surg. 1997, 15, 201e204; (b) Karotki, A.; Kruk, M.; Drobizhev, M.;
Rebane, A.; Nickel, E.; Spangler, C. W. IEEE J. Sel. Top. Quantum Electron.
2001, 7, 971e975.
8. Balaz, M.; Collins, H. A.; Dahlstedt, E.; Anderson, H. L. Org. Biomol. Chem. 2009, 7,
874e888.
9. Ryan, A.; Gehrold, A.; Perusitti, R.; Pintea, M.; Fazekas, M.; Locos, O. B.; Blaikie,
F.; Senge, M. O. Eur. J. Org. Chem. 2011, 5817e5844.
10. (a) Shultz, A. D.; Gwaltney, P. K.; Lee, H. J. Org. Chem. 1998, 63, 4034e4038; (b)
Pognon, G.; Mamardashvilli, N. Z.; Weiss, J. Tetrahedron Lett. 2007, 48,
6174e6176.
11. Easwaramoorthi, S.; Jang, S. Y.; Yoon, Z. S.; Lim, J. M.; Lee, C.-W.; Mai, C.-L.; Liu,
Y.-C.; Yeh, C.-Y.; Vura-Weis, J.; Wasielewski, M. R.; Kim, D. J. Phys. Chem. A 2008,
112, 6563e6570.
4.1.6. Zinc (II) complex of 1,2-bis(5,10,15-trimesitylporphyrin-20yl)
ethyne (6). 1H NMR (CDCl3, 400 MHz)
d
ppm 10.37 (d, J¼4.5 Hz, 4H),
8.96 (d, J¼4.5 Hz, 4H), 8.67 (s, 8H), 7.30 (s, 8H), 7.28 (s, 4H), 2.65 (s,
12H), 2.62 (s, 6H), 1.92 (s, 24H), 1.90(s, 12H); 13C NMR (CDCl3,
400 MHz) d ppm 152.6, 150.2, 149.9, 149.5, 139.2, 138.8, 137.5, 131.7,
131.3, 131.0, 127.7, 127.6, 120.1, 105.0, 21.8, 21.7 21.6; UVevis (CHCl3)
lmax nm (ε, 10ꢁ3 L molꢁ1 cmꢁ1) 414 (122), 482 (277), 563 (19), 680
(46); MS(MALDI-TOF) calcd for C96H82N8Zn2 1478.523, [MþH]þ
found: 1479.476.
12. Achelle, S.; Couleaud, P.; Baldeck, P.; Teulade-Fichou, M.-P.; Maillard, P. Eur. J.
4.1.7. Zinc (II) complex of 1,4-bis(5,10,15-trimesitylporphyrin-20yl)-
Org. Chem. 2011, 1271e1279.
buta-1,3-diyne (7). 1H NMR (CDCl3, 400 MHz)
d ppm 9.91 (d,
13. (a) Siemsen, P.; Livingston, R. C.; Diederich, F. Angew. Chem., Int. Ed. 2000, 39,
2632e2657; (b) Li, J.-H.; Liang, Y.; Zhang, X.-D. Tetrahedron 2005, 61,
1903e1907.
14. (a) Wagner, R. W.; Johnson, T. E.; Li, F.; Lindsey, J. S. J. Org. Chem. 1995, 60,
5266e5273; (b) Loewe, R. S.; Lammi, R. K.; Diers, J. R.; Kirmaier, C.; Bocian, D. F.;
Holten, D.; Lindsey, J. S. J. Mater. Chem. 2002, 12, 1530e1552.
15. Mori, A.; Kawashima, J.; Shimada, T.; Suguro, M.; Hirabayashi, K.; Nishihara, Y.
Org. Lett. 2000, 2, 2935e2937.
16. Liang, Y.; Xie, Y.-X.; Li, J.-H. J. Org. Chem. 2006, 71, 379e381.
17. Cosford, N. D. P.; Roppe, J.; Tehrani, L.; Schweiger, E. J.; Seiders, T. J.;
Chaudary, A.; Rao, S.; Varney, M. A. Bioorg. Med. Chem. Lett. 2003, 13,
351e354.
18. (a) Lee, C. H.; Lindsey, J. S. Tetrahedron 1994, 50, 11427e11440; (b) Chaleix, V.;
Sol, V.; Guilloton, M.; Granet, R.; Krausz, P. Tetrahedron Lett. 2004, 45,
5295e5299.
19. (a) Callot, H. J. Tetrahedron Lett. 1973, 14, 4987e4990; (b) Jin, L.-M.; Chen,
L.; Yin, J.-J.; Zhou, J.-M.; Guo, C. C.; Chen, Q.-Y. J. Org. Chem. 2006, 71,
527e536.
20. (a) Shultz, D. A.; Gwaltney, K. P.; Lee, H. J. Org. Chem. 1998, 63, 769e774; (b)
Merkushev, E. B.; Simakhina, N. D.; Koveshnikova, G. M. Synthesis 1980,
486e487; (c) Boyle, R. W.; Johnson, C. K.; Dolphin, D. J. Chem. Soc., Chem.
Commun. 1995, 527e528.
J¼4.5 Hz, 4H), 8.87 (d, J¼4.5 Hz, 4H), 8.63 (q, 8H), 7.3 (s, 12H), 2.64
(s, 12H), 2.62 (s, 6H), 1.87 (s, 24H), 1.86 (s, 12H); 13C NMR (CDCl3,
400 MHz)
d ppm 153.2, 150.4, 149.6, 149.4, 139.1, 138.7, 137.5, 131.9,
131.7, 131.4, 131.2, 131.1, 130.9, 128.4, 128.2, 127.7, 127.6, 120.3, 68,0
21.7, 21.6, 21.4; UVevis (CHCl3) lmax nm (ε, 10ꢁ3 L molꢁ1 cmꢁ1) 451
(5.43), 483 (5.29), 568 (4.37), 623 (4.62), 674 (4.73); MS(MALDI-
TOF) calcd for C98H82N8Zn2 1502.523, [MþH]þ found: 1503.386.
4.1.8. Zinc(II) trimer 8. It was obtained according to the new pro-
cedure, starting from tris(4-iodophenylamine) (5 mg, 0.008 mmol),
4
(3.6 equiv, 24 mg, 0.03 mmol), PdCl2(PPh3)2 (0.4 equiv,
2.2 mg,0.0032 mmol), Ph3As (1.5 equiv, 3.8 mg, 0.012 mmol) and
TBAF (100 equiv, 0.8 mL, 1 M in THF 5% water). The mixture was
stirred at reflux for 6 h. The reaction was quenched by adding DCM;
the solution was washed twice with water (100 mL) and dried over
MgSO4. The crude was purified by preparative silica gel (petroleum
ether/DCM: 50/50), to give 8 as a dark green solid (17 mg, 81%). 1H
21. Jin, L.-M.; Chen, L.; Yin, J.-J.; Guo, C.-C.; Chen, Q.-Y. Eur. J. Org. Chem. 2005,
3994e4001.
NMR (CDCl3, 400 MHz)
d
ppm 9.80 (d, J¼4.5 Hz, 6H), 8.83 (d,
22. (a) Senge, M. O.; Feng, X. Tetrahedron Lett. 1999, 40, 4165e4168; (b) Osuka, A.;
Schimidzu, H. Angew. Chem., Int. Ed. 1997, 36, 135e137.
J¼4.5 Hz, 6H), 8.64 (q, 12H), 8.06 (d, J¼8.5 Hz, 6H), 7.52 (d, J¼8.5 Hz,
6H), 7.29 (s, 18H), 2.64 (s, 18H), 2.61 (s, 9H), 1.86 (s, 54H); 13C NMR
23. Pierrat, P.; Gros, P.; Fort, Y. Org. Lett. 2005, 7, 697e700.
24. (a) Littke, A. F.; Fu, G. C. Angew. Chem., Int. Ed. 2002, 41, 4176e4211; (b) Tyk-
winski, R. R. Angew. Chem., Int. Ed. 2003, 42, 1566e1568.
(CDCl3, 400 MHz)
d ppm 152.0, 150.1, 149.7, 149.4, 146.9, 139.2,
138.8, 137.4, 132.9, 131.4, 131.2, 131.0, 130.9, 127.6, 124.5, 120.2, 119.8,
119.3, 99.4, 95.8, 92.8, 21.7, 21.6, 21.4; UVevis (CHCl3) lmax nm (ε,
10ꢁ3 L molꢁ1 cmꢁ1) 434 (389), 567 (36), 624 (67); MS(MALDI-TOF)
calcd for C165H135N13Zn3 2495.884, [MþH]þ found: 2496.727.
ꢀ
25. Chinchilla, R.; Najera, C. Chem. Rev. 2007, 107, 874e922.
26. Phan, N. T. S.; Van Der Sluys, M.; Jones, C. W. Adv. Synth. Catal. 2006, 348,
609e679.
27. (a) Reetz, M. T.; Westermann, E. Angew. Chem., Int. Ed. 2000, 39, 165e168; (b)
Roucoux, A.; Schultz, J.; Patin, H. Chem. Rev. 2002, 102, 3757e3778.
28. Anderson, H. L. Chem. Commun. 1999, 2323e2330.
Acknowledgements
29. (a) Huang, T.-H.; Chen, Y.-J.; Lo, S.-S.; Yen, W.-N.; Mai, C.-L.; Kuo, M.-C.; Yeh,
C.-Y. Dalton Trans. 2006, 2207e2213; (b) Seo, J.-W.; Jang, S. Y.; Kim, D.; Kim,
H.-J. Tetrahedron 2008, 64, 2733e2739.
30. (a) Brouwer, A. M. Pure Appl. Chem. 2011, 83, 2213e2228; (b) Magde, D.;
Brannon, J. H.; Cremers, T. L.; Olmsted, J., III. J. Phys. Chem. 1979, 83,
696e699.
ꢀ
The authors thank the Conseil Regional du Limousin for financial
support and Dr. Michel Guilloton for his help in writing the
manuscript.